001     62894
005     20200402210514.0
024 7 _ |2 pmid
|a pmid:18499676
024 7 _ |2 DOI
|a 10.1074/jbc.M709655200
024 7 _ |2 WOS
|a WOS:000257898800055
037 _ _ |a PreJuSER-62894
041 _ _ |a eng
082 _ _ |a 570
084 _ _ |2 WoS
|a Biochemistry & Molecular Biology
100 1 _ |a Bailly, A.
|b 0
|0 P:(DE-HGF)0
245 _ _ |a Modulation of P-glycoproteins by auxin transport inhibitors is mediated by interaction with immunophilins
260 _ _ |a Bethesda, Md.
|b Soc.
|c 2008
300 _ _ |a 21817 - 21826
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Journal of Biological Chemistry
|x 0021-9258
|0 3091
|v 283
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a The immunophilin-like FKBP42 TWISTED DWARF1 (TWD1) has been shown to control plant development via the positive modulation of ABCB/P-glycoprotein (PGP)-mediated transport of the plant hormone auxin. TWD1 functionally interacts with two closely related proteins, ABCB1/PGP1 and ABCB19/PGP19/MDR1, both of which exhibit the ability to bind to and be inhibited by the synthetic auxin transport inhibitor N-1-naphylphtalamic acid (NPA). They are also inhibited by flavonoid compounds, which are suspected modulators of auxin transport. The mechanisms by which flavonoids and NPA interfere with auxin efflux components are unclear. We report here the specific disruption of PGP1-TWD1 interaction by NPA and flavonoids using bioluminescence resonance energy transfer with flavonoids functioning as a classical established inhibitor of mammalian and plant PGPs. Accordingly, TWD1 was shown to mediate modulation of PGP1 efflux activity by these auxin transport inhibitors. NPA bound to both PGP1 and TWD1 but was excluded from the PGP1-TWD1 complex expressed in yeast, suggesting a transient mode of action in planta. As a consequence, auxin fluxes and gravitropism in twd1 roots are less affected by NPA treatment, whereas TWD1 gain-of-function promotes root bending. Our data support a novel model for the mode of drug-mediated P-glycoprotein regulation mediated via protein-protein interaction with immunophilin-like TWD1.
536 _ _ |a Funktion und Dysfunktion des Nervensystems
|c P33
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK409
|x 0
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a ATP-Binding Cassette Transporters: chemistry
650 _ 2 |2 MeSH
|a Arabidopsis: metabolism
650 _ 2 |2 MeSH
|a Arabidopsis Proteins: chemistry
650 _ 2 |2 MeSH
|a Biological Transport
650 _ 2 |2 MeSH
|a Cell Membrane: metabolism
650 _ 2 |2 MeSH
|a Flavonoids: chemistry
650 _ 2 |2 MeSH
|a Homozygote
650 _ 2 |2 MeSH
|a Immunophilins: chemistry
650 _ 2 |2 MeSH
|a Indoleacetic Acids: chemistry
650 _ 2 |2 MeSH
|a Luminescence
650 _ 2 |2 MeSH
|a Models, Biological
650 _ 2 |2 MeSH
|a P-Glycoprotein: chemistry
650 _ 2 |2 MeSH
|a P-Glycoproteins: chemistry
650 _ 2 |2 MeSH
|a Plant Roots: metabolism
650 _ 2 |2 MeSH
|a Protein Binding
650 _ 2 |2 MeSH
|a Tacrolimus Binding Proteins: chemistry
650 _ 7 |0 0
|2 NLM Chemicals
|a ATP-Binding Cassette Transporters
650 _ 7 |0 0
|2 NLM Chemicals
|a ATPGP1 protein, Arabidopsis
650 _ 7 |0 0
|2 NLM Chemicals
|a Arabidopsis Proteins
650 _ 7 |0 0
|2 NLM Chemicals
|a Flavonoids
650 _ 7 |0 0
|2 NLM Chemicals
|a Indoleacetic Acids
650 _ 7 |0 0
|2 NLM Chemicals
|a P-Glycoprotein
650 _ 7 |0 0
|2 NLM Chemicals
|a P-Glycoproteins
650 _ 7 |0 0
|2 NLM Chemicals
|a TWD1 protein, Arabidopsis
650 _ 7 |0 EC 5.2.1.-
|2 NLM Chemicals
|a Tacrolimus Binding Proteins
650 _ 7 |0 EC 5.2.1.8
|2 NLM Chemicals
|a Immunophilins
650 _ 7 |a J
|2 WoSType
700 1 _ |a Sovero, V.
|b 1
|0 P:(DE-HGF)0
700 1 _ |a Vincenzetti, V.
|b 2
|0 P:(DE-HGF)0
700 1 _ |a Santelia, D.
|b 3
|0 P:(DE-HGF)0
700 1 _ |a Bartnik, D.
|b 4
|u FZJ
|0 P:(DE-Juel1)VDB65461
700 1 _ |a Koenig, B. W.
|b 5
|u FZJ
|0 P:(DE-Juel1)132009
700 1 _ |a Mancuso, S.
|b 6
|0 P:(DE-HGF)0
700 1 _ |a Martinoia, E.
|b 7
|0 P:(DE-HGF)0
700 1 _ |a Geisler, M.
|b 8
|0 P:(DE-HGF)0
773 _ _ |a 10.1074/jbc.M709655200
|g Vol. 283, p. 21817 - 21826
|p 21817 - 21826
|q 283<21817 - 21826
|0 PERI:(DE-600)1474604-9
|t The @journal of biological chemistry
|v 283
|y 2008
|x 0021-9258
856 7 _ |u http://dx.doi.org/10.1074/jbc.M709655200
909 C O |o oai:juser.fz-juelich.de:62894
|p VDB
913 1 _ |k P33
|v Funktion und Dysfunktion des Nervensystems
|l Funktion und Dysfunktion des Nervensystems
|b Gesundheit
|0 G:(DE-Juel1)FUEK409
|x 0
914 1 _ |y 2008
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |k INB-2
|l Molekulare Biophysik
|d 31.12.2008
|g INB
|0 I:(DE-Juel1)VDB805
|x 0
970 _ _ |a VDB:(DE-Juel1)99807
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ISB-2-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ISB-2-20090406
981 _ _ |a I:(DE-Juel1)ICS-6-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21